Status:
COMPLETED
Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Rectal Tumors
Erectile Dysfunction
Eligibility:
MALE
18-70 years
Phase:
PHASE4
Brief Summary
Although the high prevalence of erectile dysfunction (ED) was detected among male patients after the treatment for colorectal cancer, published reports depicting the erectile dysfunction experience of...
Eligibility Criteria
Inclusion
- 18 \< Age \< 70
- Sexually active men without the consistent use of erectile aids pre-operatively
- Rectal cancer confirmed by histology
- Undergoing a bilateral nerve sparing laparoscopic rectal resection
- IIEF-5 domain score \> =20 before surgery
- Presence of a female sexual partner
- Willingness to participate in clinical research as evidenced by their signature on the informed consent form
Exclusion
- Has a history of cardiac failure, angina, or life-threatening arrhythmia within the past 6 months
- Has taken or has been prescribed nitrate medication in any form in the last 6 months
- Contraindication to sildenafil (e.g. nitrates, hypersensitivity)
- Contraindication to vacuum erection device (e.g. coagulation abnormality, stick cell disease)
- Men with a history of known penile deformity or Peyronie's disease
- Pre or postoperative androgen therapy
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01912586
Start Date
May 1 2013
End Date
June 1 2015
Last Update
June 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of General Surgery, Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, China, 510515